R.J. Reynolds Buys 12 PMTA-Pending Synthetic Nicotine Disposable E-Cigarette Products for $5 Million

Apr.22
R.J. Reynolds Buys 12 PMTA-Pending Synthetic Nicotine Disposable E-Cigarette Products for $5 Million
R.J. Reynolds Vapor Company, a division of British American Tobacco (BAT), has acquired 12 PACHA synthetic nicotine disposable e-cigarette products and related assets.

Key Highlights:

● Acquirer: R.J. Reynolds Vapor Company (a subsidiary of British American Tobacco)

● Seller: Charlie’s Holdings, Inc.

● Transaction Date: April 16, 2025 (disclosed via SEC Form 8-K on April 17)

● Assets Sold: In 2022, 12 PACHA-brand synthetic nicotine products were submitted to the PMTA, all of which are disposable e-cigarettes

● Deal Value: $5 million upfront payment + up to $4.2 million in contingent earn-out

● Regulatory Status: Products submitted under FDA’s PMTA framework; approval status not disclosed

● Strategic Implication: BAT strengthens compliant product portfolio; Charlie’s monetizes regulatory-stage assets

● Market Response: CHUC stock surged 33.33% on April 17 following the announcement


[2Firsts] On April 17, 2025, Charlie’s Holdings, Inc. filed a Form 8-K with the U.S. Securities and Exchange Commission (SEC), announcing that it had entered into and completed an asset purchase agreement with R.J. Reynolds Vapor Company, a subsidiary of British American Tobacco (BAT), on April 16.

 

The deal involves the sale of 12 synthetic nicotine disposable e-cigarette products under the PACHA brand, all of which were submitted to the U.S. Food and Drug Administration (FDA) for PMTA review in 2022. The total consideration includes a $5 million upfront cash payment, plus a one-time contingent earn-out of up to $4.2 million, based on the volume of sales generated during the first 12 months of commercialization.

 

The agreement contains standard representations, warranties, and indemnities, and is filed as Exhibit 10.1 to the Form 8-K.

 

Following the announcement, Charlie’s Holdings (ticker: CHUC) surged 33.33% on April 17, closing at $0.10 per share—its highest closing price in nearly two months. The market response underscores strong investor confidence in the transaction and the monetization potential of Charlie’s regulatory-stage assets.

 

The 12 products sold are synthetic nicotine offerings currently under PMTA review, and it remains unclear whether any have received Marketing Granted Orders (MGOs) from the FDA. For BAT, the acquisition marks another step in expanding its portfolio of regulatory-stage products. For Charlie’s, it may signal a broader effort to streamline its operations or reallocate capital.

 

With intensifying regulation across the U.S. nicotine market, PMTA-submitted products are increasingly seen as valuable strategic assets. More acquisitions of this nature are likely to follow.

 

UK Nicotine Pouch Market Soars 95%, Emerging as a New Option for Vapers
UK Nicotine Pouch Market Soars 95%, Emerging as a New Option for Vapers
The UK nicotine pouch market grew by 95% in 2024, with 32% of users transitioning from e-cigarettes. Surveys show its main advantages are discretion, health perception, and social acceptance (78%), with most users aged 33 and above.
Jun.24 by 2FIRSTS.ai
Swiss Parliament Advances Ban on Disposable E-Cigarettes; Motion Passed by National Council
Swiss Parliament Advances Ban on Disposable E-Cigarettes; Motion Passed by National Council
The Swiss National Council has passed a proposal to ban disposable e-cigarettes, which is now awaiting further review by the Senate.
Jun.05 by 2FIRSTS.ai
AVOTX Clarifies Brand Positioning to 2Firsts: Independently Operated, No OEM/ODM Services
AVOTX Clarifies Brand Positioning to 2Firsts: Independently Operated, No OEM/ODM Services
AVOTX clarified to 2Firsts that it is an independently operated consumer brand and does not offer OEM/ODM services.
Jul.02
Malta Health Authority Issues Warning on Nicotine Pouches, Plans Inclusion in Future Tobacco Control Strategy
Malta Health Authority Issues Warning on Nicotine Pouches, Plans Inclusion in Future Tobacco Control Strategy
Malta’s health authorities warn of the dangers of nicotine pouches as several European countries initiate bans.
Jul.08
Ispire Clarifies: Malaysia Plant Does Not Involve Nicotine or Cannabis Products, All Production for Export Only
Ispire Clarifies: Malaysia Plant Does Not Involve Nicotine or Cannabis Products, All Production for Export Only
Ispire stated that its Malaysia facility complies with local laws and only produces semi-finished vaporizer hardware without nicotine or cannabis. All products are for export and not distributed or sold in the local market.
Jun.10 by 2FIRSTS.ai
Vuse Sales Halt Offset by Cost Controls; BAT Malaysia Reports $17 Million Net Profit in H1
Vuse Sales Halt Offset by Cost Controls; BAT Malaysia Reports $17 Million Net Profit in H1
In the first half of fiscal year 2025, British American Tobacco Malaysia reported a net profit of $17.07 million. The company attributed the gains to improved cost efficiency and a more focused product portfolio following the discontinuation of its Vuse e-cigarette operations in the country.
Jul.29 by 2FIRSTS.ai